# The Medicines (Products for Human Use) (Fees) Regulations 2016, Paragraph 5: Outgoing mutual recognition application


As regards the fee payable under regulation 17 in connection with an application—
(a) to which paragraph 36(2) of Part 3 of Schedule 2 applies—
(i) 25% of that fee shall be payable at the time when, in connection with the application or set of applications for regulatory assistance, a request is made under the second sub-paragraph of Article 28(1) of the 2001 Directive for an assessment report to be prepared or updated; and
(ii) 75% of that fee shall become payable within 30 days following written notice from the licensing authority that the regulatory assistance is at an end;
(b) to which paragraph 36(3), (4) or (5), of Part 3 of Schedule 2 applies—
(i) 50% of that fee shall be payable at the time when, in connection with the application or set of applications for regulatory assistance, a request is made under the second sub-paragraph of Article 28(1) of the 2001 Directive for an assessment report to be prepared or updated, and
(ii) 50% of that fee shall become payable within 30 days following written notice from the licensing authority that the regulatory assistance is at an end,
if the applicant so requests in writing.

---
Source: https://www.legislation.gov.uk/uksi/2016/190/schedule/6/paragraph/5 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/schedule-6/paragraph-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.